Test That Could Detect Cancer in Early Stages Under Review by the FDA
· Telemundo McAllen (KTLM)
A blood test designed to detect signals of various types of cancer in seemingly healthy individuals faces its first major regulatory hurdle on Wednesday, as U.S. government advisors review how well it works. The test from Grail Inc. seeks fragments of DNA shed by tumor cells, an emerging detection approach aimed at identifying multiple types of cancer with a single blood draw. Cancer screening tests are purported to identify tumors in early stages when they are easier to treat. A multi-cancer screening test would represent a shift from the limited number of currently recommended tests (including mammograms and colonoscopies) that look for one cancer at a time.
AI summary · Source: Telemundo McAllen (KTLM) →
